tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2021 Jul 21;27(10).
doi: 10.3201/eid2710.211427. Online ahead of print.
Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021
Nicolas Vignier, Vincent Bérot, Nathalie Bonnave, Sandrine Peugny, Mathilde Ballet, Estelle Jacoud, Céline Michaud, Mélanie Gaillet, Félix Djossou, Denis Blanchet, Anne Lavergne, Magalie Demar, Mathieu Nacher, Dominique Rousset, Loïc Epelboin
Abstract
An outbreak of severe acute respiratory syndrome coronavirus 2 caused by the Gamma variant of concern infected 24/44 (55%) employees of a gold mine in French Guiana (87% symptomatic, no severe forms). The attack rate was 60% (15/25) among fully vaccinated miners and 75% (3/4) among unvaccinated miners without a history of infection.
Keywords: BNT162 vaccine; COVID-19; French Guiana; Gamma variant of concern; SARS-CoV-2; breakthrough; coronavirus disease; gold miner; outbreak; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccines; variants; viruses; zoonoses.
. 2021 Jul 21;27(10).
doi: 10.3201/eid2710.211427. Online ahead of print.
Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021
Nicolas Vignier, Vincent Bérot, Nathalie Bonnave, Sandrine Peugny, Mathilde Ballet, Estelle Jacoud, Céline Michaud, Mélanie Gaillet, Félix Djossou, Denis Blanchet, Anne Lavergne, Magalie Demar, Mathieu Nacher, Dominique Rousset, Loïc Epelboin
- PMID: 34289335
- DOI: 10.3201/eid2710.211427
Abstract
An outbreak of severe acute respiratory syndrome coronavirus 2 caused by the Gamma variant of concern infected 24/44 (55%) employees of a gold mine in French Guiana (87% symptomatic, no severe forms). The attack rate was 60% (15/25) among fully vaccinated miners and 75% (3/4) among unvaccinated miners without a history of infection.
Keywords: BNT162 vaccine; COVID-19; French Guiana; Gamma variant of concern; SARS-CoV-2; breakthrough; coronavirus disease; gold miner; outbreak; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccines; variants; viruses; zoonoses.